ANI Pharmaceuticals Inc

-0.87 (-2.30%)
Other Pre-Announcement, Mergers / Acquisitions, Equity Financing / Related

ANI Pharmaceuticals To Acquire Novitium Pharma

Published: 03/09/2021 11:58 GMT
ANI Pharmaceuticals Inc (ANIP) - Ani Pharmaceuticals to Acquire Novitium Pharma, Strengthening Research and Development Engine and Expanding Generics and Cdmo Business.
Ani Pharmaceuticals Inc - Purchase Price of $163.5 Million.
Ani Pharmaceuticals Inc - Deal Expected to Be Accretive to Adjusted Non-GAAP Earnings per Share Within First 12 Months.
Ani Pharmaceuticals - Deal Price Included $89.5 Million in Cash and $74 Million in Equity Plus 2 Potential Future Cash Earn-outs of Upto $46.5 Million.
Ani Pharmaceuticals Inc - Transaction Has Been Approved by Ani Board of Directors.
Ani Pharmaceuticals Inc - Equity Holders of Novitium Have Approved Transaction.
Ani Pharmaceuticals - Transaction is Expected to Add About $15 Million to Adjusted EBITDA in Second Half of 2021.
Ani Pharma - to Finance Deal With $300 Million Term Loan B, Issuance of $74 Million in Equity to Sellers, $25 Million Pipe Investment by Ampersand Capital Partners.